Literature DB >> 12003687

Neuropsychiatric aspects of human immunodeficiency virus (HIV) infection.

Francisco Fernandez1.   

Abstract

Human immunodeficiency virus (HIV) infection with central nervous system (CNS) involvement causes a variety of psychiatric complications among a significant proportion of infected individuals. A cure for the fully developed AIDS related to HIV infection remains elusive, and HIV/AIDS is a leading cause of death among adults between the ages of 25 and 44. Life expectancy, however, has gradually increased over the years, resulting in a concern for a potential increase in the incidence of secondary psychiatric manifestations. Knowledge of the neuropathology of HIV-CNS dysfunction and familiarity with its clinical presentation can aid clinicians in a determination of the appropriate therapy inclusive of psychiatric care that may be useful for a specific individual in their treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003687     DOI: 10.1007/s11920-002-0034-5

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  18 in total

1.  Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.

Authors:  G J Dore; P K Correll; Y Li; J M Kaldor; D A Cooper; B J Brew
Journal:  AIDS       Date:  1999-07-09       Impact factor: 4.177

2.  Risk factors for suicide attempts in a human immunodeficiency virus screening program.

Authors:  J R Rundell; K M Kyle; G R Brown; J L Thomason
Journal:  Psychosomatics       Date:  1992       Impact factor: 2.386

Review 3.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

Review 4.  HIV-1 protease inhibitors. A review for clinicians.

Authors:  S G Deeks; M Smith; M Holodniy; J O Kahn
Journal:  JAMA       Date:  1997-01-08       Impact factor: 56.272

5.  CSF, plasma viral load and HIV associated dementia.

Authors:  K Robertson; S Fiscus; C Kapoor; W Robertson; G Schneider; R Shepard; L Howe; S Silva; C Hall
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

6.  Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.

Authors:  J J Sidtis; C Gatsonis; R W Price; E J Singer; A C Collier; D D Richman; M S Hirsch; F W Schaerf; M A Fischl; K Kieburtz
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

7.  Treatment of severe, refractory agitation with a haloperidol drip.

Authors:  F Fernandez; V F Holmes; F Adams; J J Kavanaugh
Journal:  J Clin Psychiatry       Date:  1988-06       Impact factor: 4.384

8.  A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.

Authors:  W Breitbart; R Marotta; M M Platt; H Weisman; M Derevenco; C Grau; K Corbera; S Raymond; S Lund; P Jacobson
Journal:  Am J Psychiatry       Date:  1996-02       Impact factor: 18.112

Review 9.  New-onset psychosis in HIV-infected patients.

Authors:  M J Harris; D V Jeste; A Gleghorn; D D Sewell
Journal:  J Clin Psychiatry       Date:  1991-09       Impact factor: 4.384

Review 10.  Management of delirium in terminally ill AIDS patients.

Authors:  F Fernandez; J K Levy; P W Mansell
Journal:  Int J Psychiatry Med       Date:  1989       Impact factor: 1.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.